The Business Times
SUBSCRIBERS

Drugmaker Takeda to zoom in on emerging markets

Published Wed, Feb 25, 2015 · 09:50 PM
Share this article.

Singapore

ASIA'S largest drugmaker Takeda Pharmaceutical has streamlined its Singapore operations in a move that reflects its focus on emerging markets.

Its new Biopolis office, costing an undisclosed sum, will now house its emerging-markets business unit headquarters that was previously based in Zurich, as well as its regional research and development centre and its vaccine business unit.

The Japanese company, which has a market capitalisation of more than 4.8 trillion yen (S$54.7 billi…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here